Company / Operating Income
Boston Scientific Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$3.6B
FY2025
5-year range
$1.5B / $3.6B
FY2021-FY2025
Trend
+38.8%
vs FY2024
Sector context
#10 of 156
Health Care
What the data says
Among 156 Health Care companies, Boston Scientific is in the top 6% for operating income. Operating Income has increased for 5 consecutive years, from $1.5B in FY2020 to $3.6B in FY2025.
Based on SEC 10-K filings.
$3.6B in FY2025 with a 5-year CAGR of +19.1%. Top quartile in the Health Care sector.
Improved from $2.3B to $3.6B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +29.9%
- 5-Year CAGR
- +19.1%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 156This company $3.6B Sector average $733.1M
▼
+392.9% above sector average
Key checks
Key Insights
- Boston Scientific's operating income has grown for 5 consecutive years.
- 5-year CAGR of +19.1%, indicating consistent growth.
- In FY2025, operating income increased 38.8% year-over-year.
- Ranks #10 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6B | +38.8% |
| FY2024 | $2.6B | +11.1% |
| FY2023 | $2.3B | +42.1% |
| FY2022 | $1.6B | +8.6% |
| FY2021 | $1.5B | +0.8% |
| FY2020 | $1.5B | -0.8% |
| FY2019 | $1.5B | +0.8% |
| FY2018 | $1.5B | +17.2% |
| FY2017 | $1.3B | +187.5% |
| FY2016 | $447.0M | +258.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026